Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15878 | 618 | 38.2 | 68% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
461 | 15321 | NEUROPEPTIDE Y//GLUCAGON LIKE PEPTIDE 1//GLP 1 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GLUCAGON RECEPTOR | Author keyword | 22 | 51% | 5% | 31 |
2 | GLUCAGON RECEPTOR GENE | Author keyword | 21 | 85% | 2% | 11 |
3 | GLUCAGON ANTAGONIST | Author keyword | 18 | 89% | 1% | 8 |
4 | GLUCAGON RECEPTOR ANTAGONIST | Author keyword | 15 | 68% | 2% | 13 |
5 | GLUCAGON RECEPTOR ANTAGONISTS | Author keyword | 9 | 83% | 1% | 5 |
6 | GLUCAGON ANTAGONISTS | Author keyword | 6 | 71% | 1% | 5 |
7 | METAB DISORDERS MOL ENDOCRINOL | Address | 4 | 75% | 0% | 3 |
8 | PANCREATIC ALPHA CELL | Author keyword | 2 | 38% | 1% | 5 |
9 | ALPHA CELL | Author keyword | 2 | 15% | 2% | 14 |
10 | GLUCAGON RECEPTOR GCGR | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GLUCAGON RECEPTOR | 22 | 51% | 5% | 31 | Search GLUCAGON+RECEPTOR | Search GLUCAGON+RECEPTOR |
2 | GLUCAGON RECEPTOR GENE | 21 | 85% | 2% | 11 | Search GLUCAGON+RECEPTOR+GENE | Search GLUCAGON+RECEPTOR+GENE |
3 | GLUCAGON ANTAGONIST | 18 | 89% | 1% | 8 | Search GLUCAGON+ANTAGONIST | Search GLUCAGON+ANTAGONIST |
4 | GLUCAGON RECEPTOR ANTAGONIST | 15 | 68% | 2% | 13 | Search GLUCAGON+RECEPTOR+ANTAGONIST | Search GLUCAGON+RECEPTOR+ANTAGONIST |
5 | GLUCAGON RECEPTOR ANTAGONISTS | 9 | 83% | 1% | 5 | Search GLUCAGON+RECEPTOR+ANTAGONISTS | Search GLUCAGON+RECEPTOR+ANTAGONISTS |
6 | GLUCAGON ANTAGONISTS | 6 | 71% | 1% | 5 | Search GLUCAGON+ANTAGONISTS | Search GLUCAGON+ANTAGONISTS |
7 | PANCREATIC ALPHA CELL | 2 | 38% | 1% | 5 | Search PANCREATIC+ALPHA+CELL | Search PANCREATIC+ALPHA+CELL |
8 | ALPHA CELL | 2 | 15% | 2% | 14 | Search ALPHA+CELL | Search ALPHA+CELL |
9 | GLUCAGON RECEPTOR GCGR | 2 | 67% | 0% | 2 | Search GLUCAGON+RECEPTOR+GCGR | Search GLUCAGON+RECEPTOR+GCGR |
10 | PANCREATIC ALPHA CELLS | 1 | 31% | 1% | 4 | Search PANCREATIC+ALPHA+CELLS | Search PANCREATIC+ALPHA+CELLS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ALPHA CELL HYPERPLASIA | 25 | 73% | 3% | 19 |
2 | ENDOGENOUS GLUCAGON | 19 | 80% | 2% | 12 |
3 | HYPERGLUCAGONEMIA | 19 | 36% | 7% | 43 |
4 | ALKYLIDENE HYDRAZIDES | 15 | 82% | 1% | 9 |
5 | SWITCH OFF HYPOTHESIS | 14 | 55% | 3% | 17 |
6 | REPLACEMENT ANALOGS | 7 | 53% | 2% | 10 |
7 | PANCREATIC ALPHA CELLS | 6 | 27% | 3% | 19 |
8 | INTACT ISLETS | 6 | 32% | 2% | 15 |
9 | A CELLS | 6 | 23% | 4% | 22 |
10 | CONFORMATIONAL CONSIDERATIONS | 6 | 100% | 1% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Minireview: Glucagon in the Pathogenesis of Hypoglycemia and Hyperglycemia in Diabetes | 2012 | 41 | 87 | 45% |
ATP-regulated potassium channels and voltage-gated calcium channels in pancreatic alpha and beta cells: similar functions but reciprocal effects on secretion | 2014 | 4 | 77 | 47% |
Pancreatic alpha-Cell Hyperplasia: Facts and Myths | 2014 | 4 | 48 | 46% |
Regulation of glucagon secretion by glucose: paracrine, intrinsic or both? | 2011 | 36 | 57 | 47% |
Glucagon antagonism as a potential therapeutic target in type 2 diabetes | 2011 | 26 | 69 | 54% |
The role of dysregulated glucagon secretion in type 2 diabetes | 2011 | 41 | 57 | 39% |
Lack of glucagon receptor signaling and its implications beyond glucose homeostasis | 2015 | 1 | 66 | 41% |
Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes | 2009 | 37 | 71 | 54% |
A survey of small molecule glucagon receptor antagonists from recent patents (2006-2010) | 2011 | 7 | 35 | 77% |
Physiology of the pancreatic alpha-ce glucose secretion: role in glucose homeostasis and diabetes | 2008 | 73 | 147 | 30% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | METAB DISORDERS MOL ENDOCRINOL | 4 | 75% | 0.5% | 3 |
2 | METAB DISORDER MOL ENDOCRINOL | 1 | 100% | 0.3% | 2 |
3 | UNITE CHIM BIOL NUTR | 1 | 100% | 0.3% | 2 |
4 | CARCINOID NEUROENDOCRINE TUMOR | 1 | 30% | 0.5% | 3 |
5 | CARDIOVASC METAB ENDOCRINE DIS CHEM | 1 | 40% | 0.3% | 2 |
6 | COMBINATORIAL CHEM TECHNOL | 1 | 40% | 0.3% | 2 |
7 | PACIFIC NW DIABET | 1 | 33% | 0.3% | 2 |
8 | ST S AD TAT RECOGNIT | 1 | 33% | 0.3% | 2 |
9 | ENDOCRINE DISCOVERY | 1 | 17% | 0.6% | 4 |
10 | GUANGDONG PLANT OURCES LIFE SCI | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000169091 | PANCREATIC DIABETES//INSULIN LIKE IMMUNOREACTIVITY//CALCIFYING PANCREATITIS |
2 | 0.0000117335 | GLUCAGON LIKE PEPTIDE 1//EXENATIDE//LIRAGLUTIDE |
3 | 0.0000103267 | SECRETIN RECEPTOR//SECRETIN//SECRETIN RECEPTORS |
4 | 0.0000086505 | UNITE ENDOCRINOL METAB//PANCREATIC BETA CELL//INSULIN RELEASE |
5 | 0.0000077779 | C PEPTICLE//CLIN PHYSIOL METAB UNIT//HENRY WELLCOME S EGRATED CELL SIGNALLING |
6 | 0.0000071607 | INSULIN DEGRADING ENZYME//NEPRILYSIN//INSULYSIN |
7 | 0.0000069607 | IMMUNOHISTOCHEMISTRY OF BONE//FRESH FROZEN SECTION//ADULT BONE |
8 | 0.0000068975 | GLUCONEOGENESIS//GLYCOGENOLYSIS//ENDOGENOUS GLUCOSE PRODUCTION |
9 | 0.0000065984 | HEPATIC AMINO NITROGEN CONVERSION//UREA SYNTHESIS//AMMONIOGENESIS |
10 | 0.0000063924 | HYPOGLYCAEMIA UNAWARENESS//COUNTERREGULATION//HYPOGLYCAEMIA |